论文信息 - Long-term Impact of Early MS Treatment with Interferon Beta-1b (IFNB-1b): Clinical, MRI, Employment, and Patient-Reported Outcomes (PROs) at the 11-Year Follow-up of BENEFIT (BENEFIT 11) (P7.012) - 字舞流文

Long-term Impact of Early MS Treatment with Interferon Beta-1b (IFNB-1b): Clinical, MRI, Employment, and Patient-Reported Outcomes (PROs) at the 11-Year Follow-up of BENEFIT (BENEFIT 11) (P7.012)

David H. Miller | F. Barkhof | X. Montalban | L. Kappos | H. Hartung | M. Freedman | B. Hemmer | G. Edan | S. Schippling | C. Pohl | E. Wicklein | R. Sandbrink | E. Fox | D. Pleimes | G. Suárez | Andrea Schulze